Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...

World Rheumatoid Arthritis Day on February 2, 2025, is a powerful reminder of the importance of understanding rheumatoid ...

The Public Health Department has reported three new suspected cases of Guillain-Barré Syndrome (GBS) on Sunday, bringing the total to 158 suspected cases and five suspected deaths in the Pune district ...

For children, tantrums are their own version of anxiety attacks. When they are feeling especially anxious and cannot verbally ...

Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

After climbing to around the 1.05300 level early on Monday of last week, the EUR/USD began to see buyer remorse hit the currency pair. As the <a targ ...